Estimativas de analistas de Wall Street para The Cooper Companies, Inc. (COO): preço alvo de consenso, recomendações de compra/manter/venda e previsões de receita, LPA e EBITDA para os próximos exercícios.
Surpresas de Resultados Recentes
| Data | LPA Real | LPA Estimado | vs Est. |
|---|---|---|---|
| 2026-12-03 | $1.11 | ||
| 2026-09-09 | $1.15 | $1.12 | +2.7% |
| 2026-06-04 | $1.21 | $1.10 | +10.0% |
| 2026-03-05 | $1.10 | $1.03 | +6.8% |
| 2025-12-04 | $1.15 | $1.11 | +3.6% |
| 2025-08-27 | $1.10 | $1.07 | +2.8% |
| 2025-05-29 | $0.96 | $0.93 | +3.4% |
| 2025-03-06 | $0.92 | $0.91 | +0.7% |
Índices de avaliação
| Índice P/L | 18.64 |
| Preço / Valor contábil | 1.27 |
| Dividend Yield | 0.00% |
Demonstração de Resultados (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Receita | $1.97B | $2.14B | $2.53B | $2.65B | $2.43B | $2.92B | $3.31B | $3.59B | $3.90B | $4.09B |
| Custo da Receita | $793.7M | $773.2M | $900.5M | $896.6M | $896.1M | $966.7M | $1.17B | $1.24B | $1.30B | $1.61B |
| Lucro Bruto | $1.17B | $1.37B | $1.63B | $1.76B | $1.53B | $1.96B | $2.14B | $2.36B | $2.60B | $2.48B |
| P&D | $65.4M | $69.2M | $84.8M | $86.7M | $93.3M | $92.7M | $110.3M | $137.4M | $155.1M | $172.2M |
| Despesas Gerais e Administrativas | $722.8M | $799.1M | $973.3M | $996.6M | $992.5M | $1.21B | $1.34B | $1.50B | $1.53B | $1.63B |
| Despesas Operacionais | $849.0M | $936.7M | $1.20B | $1.23B | $1.22B | $1.45B | $1.63B | $1.82B | $1.89B | $1.80B |
| Lucro Operacional | $324.1M | $429.1M | $403.1M | $546.7M | $311.8M | $505.8M | $507.6M | $533.1M | $705.7M | $682.9M |
| EBITDA | $520.1M | $615.8M | $689.7M | $826.2M | $590.4M | $823.9M | $878.7M | $885.9M | $1.07B | $1.05B |
| Despesas com Juros | $26.2M | $33.4M | $82.7M | $68.0M | $36.8M | $23.1M | $57.3M | $105.3M | $114.3M | $100.0M |
| Lucro Antes de Impostos | $295.6M | $394.0M | $331.9M | $477.4M | $266.5M | $491.5M | $475.3M | $412.9M | $582.3M | $566.5M |
| Imposto | $20.7M | $21.1M | $192.0M | $10.7M | $28.1M | -$2.45B | $89.5M | $118.7M | $190.0M | $191.6M |
| Lucro Líquido | $273.9M | $372.9M | $139.9M | $466.7M | $238.4M | $2.94B | $385.8M | $294.2M | $392.3M | $374.9M |
| LPA | $5.65 | $7.63 | $2.85 | $9.47 | $4.86 | $14.93 | $1.96 | $1.49 | $1.97 | $1.88 |
| LPA Diluído | $5.59 | $7.52 | $2.81 | $9.32 | $4.81 | $14.79 | $1.94 | $1.48 | $1.96 | $1.87 |
| Ações em Circulação (Diluídas) | $196.0M | $198.4M | $198.8M | $200.2M | $198.2M | $199.4M | $198.8M | $199.2M | $200.4M | $200.0M |
Preço
| Preço | $54.61 |
| Capitalização | $10.7B |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: DOCS · FMS · HOLX · ICLR · NBIX · SMMT · SNN
Explorar setor: Healthcare · Medical - Instruments & Supplies
Mais seções de COO: Resumo · Financeiros · Avaliação · Estatísticas · Técnico · Propriedade · Notícias · Eventos
Descubra mais: Radar — sinais de ações subvalorizadas · Academia de Investimento — aprenda a analisar ações